On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now


ISW Holdings (ISWH) Along with Partner Bit5ive Poised to Leverage Growing Potential in Crypto Mining Equipment Space

  • With economy gradually normalizing, one report projects marijuana stocks will “rebound with vigor”
  • ISWH, new partner positioned to be powerful players in this promising sector
  • The two companies recently announced the finalization of new Proceso S19 Pod5ive data center design

As the cannabis space heats back up again, investing in the promising market could be worth looking at. A recent InvestorPlace article noted that pot stocks will “soar” in the second half of 2020, and industry newcomer ISW Holdings (OTC: ISWH), a brand-management portfolio company with a new partnership in the  crypto mining equipment sector, is ideally positioned in the space.

“The economy is gradually normalizing,” reported one InvestorPlace markets analyst. “And stocks — particularly marijuana stocks — are rebounding with vigor. The ETFMG Alternative Harvest ETF is up more than 50% from its March lows.

“I’d stick with this big rally in pot stocks,” the article continues. “It’s only going to heat up in the second-half of 2020. . . . Revenue trends will improve on the back of more store openings and new products. Margin trends will improve thanks to curbed production and cost-cutting measures. Profit trends will materially improve alongside higher revenues and margins. And pots stocks will soar.”

ISWH and its new partner, Bit5ive, look to be powerful players in the cannabis market. They two have joined together to build and deliver the single most elegant and efficient data center pods in the world (http://ibn.fm/g36JM). The two companies took a major step forward in accomplishing that earlier this month when they announced the finalization of the new Proceso S19 Pod5ive data center design, which is capable of powering 1MW of computing mining power. Geared primarily for the cryptocurrency mining industry, the Proceso S19 Pod5ive Data Center offers next-generation, dynamic self-management functionality, plug-and-play operation, virtually nonexistent maintenance needs, and an industry best-in-class 1.025 PUE

Bit5ive is targeting the first deployments beginning in August, with its initial pod delivery bound to the 100-MW renewable energy Bit5ive LLC project in Pennsylvania. “The S19 Pod5ive Data Center has been engineered from the ground up to deliver an industry leading Power Usage Effectiveness (‘PUE’) score of 1.025,” said ISWH president Alonzo Pierce. “If you eliminate everything superfluous to maximum performance, optimize every remaining factor, and then integrate it into a renewable energy substrate to drive costs down to some of the lowest levels available anywhere in the world, this is what you get.”

Based in Nevada, ISW Holdings is a diversified portfolio company comprised of essential business lines that serve consumer product demands. The company’s expertise lies in strategic brand development and early-growth facilitation, as well as brand identity through its proprietary procurement process. Together with its partners, ISWH seeks to provide a structure that meets large scalability demands as well as anticipated marketplace needs. ISWH maneuvers its proprietary companies through critical stages of market development, which includes conceptualization, go-to-market strategies, engineering, product integration and distribution efficiency.

For more information, visit the company’s website at www.ISWHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to ISWH are available in the company’s newsroom at http://ibn.fm/ISWH

From Our Blog

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is “One to Watch”

September 25, 2020

CNS Pharmaceuticals’ lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and currently incurable form of brain cancer. In a Phase I clinical trial of Berubicin in malignant brain tumors, 44% of patients experienced a statistically significant improvement in clinical benefit. In preclinical studies, the company’s second drug candidate, […]

Rotate your device 90° to view site.